Mustafa Gulec
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Mustafa Gulec has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Murat Boysan
Yuzuncu Yil University Faculty of Arts and Science, Department of Psychology, Van, Turkey
3 shared publicationsYavuz Selvi
3 shared publicationsAdem Aydin
2 shared publicationsElif Oral
Izmir Katip Celebi University Faculty of Medicine, Department of Psychiatry, İzmir, Turkey
2 shared publicationsLutfullah Besiroglu
Izmir Katip Celebi University Faculty of Medicine, Department of Psychiatry, İzmir, Turkey
2 shared publicationsTemel Kalafat
Ankara University Faculty of Educational Sciences, Department of Psychological Counselling, Ankara, Turkey
2 shared publications
Latest Publications
- 1 January 2017
- Published by Elsevier in Addictive Behaviors
- Vol. 64, 247-252
Psychometric properties of the Turkish version of the Internet Addiction Test (IAT)
- 1 January 2017
- Published by Elsevier in Addictive Behaviors
- Vol. 64, 247-252
Psychometric properties of the Turkish version of the Internet Addiction Test (IAT)
- 26 December 2014
- Published by Turk Noropsikiyatri Dernegi in Archives of Neuropsychiatry
- Vol. 51 (4) , 355-362
Development of a Psychometric Instrument Based on the Inference-Based Approach to Obsessive-Compulsive Disorder: The Obsessional Probabilistic Inference Scale
The current article addresses the validation of the construct of obsessional probabilistic inference in clinical and non-clinical samples. Obsessional probabilistic inference or obsessional doubt refers to a type of inferential process resulting in the belief that a state of affairs "maybe" causes development of a maladaptive cognitive coping style in terms of obsessing. The latent structure of the Obsessional Probabilistic Inference Scale (OPIS) was evaluated with confirmatory factor analysis. Explanatory and confirmatory factor analyses indicated that a one-factor solution was satisfactory for the instrument, assessing a unidimensional psychological construct. The OPIS was shown to have high internal consistency in all samples, as well as temporal stability, relying on predominantly non-clinical individuals. The scale exhibited high convergent validity and successfully discriminated patients with obsessive-compulsive disorder from both depressive patients and controls. The findings replicated and extended the role of reasoning process in the development and maintenance of obsessive compulsive symptoms. The results are discussed in regard to assumptions of the inference-based approach to obsessive-compulsive disorder.
- 26 December 2014
- Published by Turk Noropsikiyatri Dernegi in Archives of Neuropsychiatry
- Vol. 51 (4) , 355-362
Development of a Psychometric Instrument Based on the Inference-Based Approach to Obsessive-Compulsive Disorder: The Obsessional Probabilistic Inference Scale
The current article addresses the validation of the construct of obsessional probabilistic inference in clinical and non-clinical samples. Obsessional probabilistic inference or obsessional doubt refers to a type of inferential process resulting in the belief that a state of affairs "maybe" causes development of a maladaptive cognitive coping style in terms of obsessing. The latent structure of the Obsessional Probabilistic Inference Scale (OPIS) was evaluated with confirmatory factor analysis. Explanatory and confirmatory factor analyses indicated that a one-factor solution was satisfactory for the instrument, assessing a unidimensional psychological construct. The OPIS was shown to have high internal consistency in all samples, as well as temporal stability, relying on predominantly non-clinical individuals. The scale exhibited high convergent validity and successfully discriminated patients with obsessive-compulsive disorder from both depressive patients and controls. The findings replicated and extended the role of reasoning process in the development and maintenance of obsessive compulsive symptoms. The results are discussed in regard to assumptions of the inference-based approach to obsessive-compulsive disorder.
- Open Access
- 1 January 2014
- Published by ScopeMed in Psikiyatride Güncel Yaklaşımlar
- Vol. 6 (3) , 1-283
The pathophysiological, clinical, and therapeutic aspects of narcolepsy
- 1 January 2014
- Published by ScopeMed in Psikiyatride Güncel Yaklaşımlar
- Vol. 6 (3) , 1-283
Open AccessThe pathophysiological, clinical, and therapeutic aspects of narcolepsy
- 5 June 2013
- Published by Turk Noropsikiyatri Dernegi in Archives of Neuropsychiatry
- Vol. 50 (2) , 147-153
Travma Sonrası Bilişler Envanteri’nin (TSBE) Türkçe Formu’nun Klinik Olmayan Örneklemde Psikometrik Özellikleri
Background: Cognitive theories of posttraumatic stress disorder have increasingly been recognised. The Posttraumatic Cognitions Inventory is a promising self-report instrument to assess negative cognitions associated with posttraumatic distress. Method: In this study, we examined the psychometric properties of the Posttraumatic Cognitions Inventory in 653 non-clinical Turkish college students. 185 participants reported having experienced various types of trauma. Results: Confirmatory factor analyses replicated the original three-factor structure without excluding any items. Total and subscale scores of the instrument revealed strong connections with severity of depression, anxiety, and dissociative symptoms. Concurrent validity of the Self-Blame subscale was specific to subtype of trauma. The total and the subscales of the instrument had high internal consistency and adequate temporal stability over a two-week interval with an exception of the Self-Blame subscale. The correlation coefficient between the two applications was extremely low for the subscale. Conclusion: We assume that the Self-Blame subscale fails to perform well among individuals who had experienced an aversive event other than interpersonal trauma. The PTCI revealed adequate reliability and validity in a non-clinical Turkish sample. (Archives of Neuropsychiatry, 2013; 50: 147-153)Conflict of interest: The authors reported no conflict of interest related to this article
- 5 June 2013
- Published by Turk Noropsikiyatri Dernegi in Archives of Neuropsychiatry
- Vol. 50 (2) , 147-153
Travma Sonrası Bilişler Envanteri’nin (TSBE) Türkçe Formu’nun Klinik Olmayan Örneklemde Psikometrik Özellikleri
Background: Cognitive theories of posttraumatic stress disorder have increasingly been recognised. The Posttraumatic Cognitions Inventory is a promising self-report instrument to assess negative cognitions associated with posttraumatic distress. Method: In this study, we examined the psychometric properties of the Posttraumatic Cognitions Inventory in 653 non-clinical Turkish college students. 185 participants reported having experienced various types of trauma. Results: Confirmatory factor analyses replicated the original three-factor structure without excluding any items. Total and subscale scores of the instrument revealed strong connections with severity of depression, anxiety, and dissociative symptoms. Concurrent validity of the Self-Blame subscale was specific to subtype of trauma. The total and the subscales of the instrument had high internal consistency and adequate temporal stability over a two-week interval with an exception of the Self-Blame subscale. The correlation coefficient between the two applications was extremely low for the subscale. Conclusion: We assume that the Self-Blame subscale fails to perform well among individuals who had experienced an aversive event other than interpersonal trauma. The PTCI revealed adequate reliability and validity in a non-clinical Turkish sample. (Archives of Neuropsychiatry, 2013; 50: 147-153)Conflict of interest: The authors reported no conflict of interest related to this article
- Open Access
- 21 December 2012
- Published by Wiley in Psychiatry and Clinical Neurosciences
- Vol. 67 (1) , 50-58
Mirtazapine protects against cisplatin‐induced oxidative stress and DNA damage in the rat brain
Aim: Cisplatin chemotherapy is associated with neurotoxicity, and oxidative stress might play an important role in the pathogenesis. Mirtazapine may be a preventative agent via its less‐known antioxidant properties. The aim of this study was to examine the potential chemoprotective effects of mirtazapine against cisplatin‐induced oxidative stress and DNA damage.Methods: Twenty‐four rats were divided equally into four groups: control; cisplatin (10 mg/kg i.p.); cisplatin plus mirtazapine (10–30 mg/kg, respectively i.p and p.o.); and mirtazapine (30 mg/kg p.o.). The rats were killed at the end of the 14th day of treatment. Brain tissue was examined with regard to antioxidant/oxidant biochemical parameters.Results: Although glutathione (tGSH) and nitric oxide (NO) end product mean scores were found to be statistically higher in the control group when compared with the cisplatin group (72.44% and 61.99% percentage change [PC], respectively), malondialdehyde (MDA), myeloperoxidase (MPO), and 8‐hydroxyguanine (8‐OH‐GUA) mean scores were statistically lower in the control group in comparison with the cisplatin group (−55.48%, −67.99%, and −48.81% PC, respectively; P < 0.01). Finally, tGSH and NO end product levels were restored to normal (85.90% and 55.30% PC, respectively), and MDA, MPO, and 8‐OH‐GUA were significantly reduced by treatment with mirtazapine (−60.50%, −78.59%, and −38.10% PC, respectively; P < 0.01).Conclusion: Mirtazapine has chemoprotective effects against cisplatin‐induced oxidative stress and DNA damage in the rat brain, which may be attributed to its antioxidant capabilities. It would be useful to investigate whether cisplatin at the desired doses can be given concurrently with mirtazapine.
- 21 December 2012
- Published by Wiley in Psychiatry and Clinical Neurosciences
- Vol. 67 (1) , 50-58
Open AccessMirtazapine protects against cisplatin‐induced oxidative stress and DNA damage in the rat brain
Aim: Cisplatin chemotherapy is associated with neurotoxicity, and oxidative stress might play an important role in the pathogenesis. Mirtazapine may be a preventative agent via its less‐known antioxidant properties. The aim of this study was to examine the potential chemoprotective effects of mirtazapine against cisplatin‐induced oxidative stress and DNA damage.Methods: Twenty‐four rats were divided equally into four groups: control; cisplatin (10 mg/kg i.p.); cisplatin plus mirtazapine (10–30 mg/kg, respectively i.p and p.o.); and mirtazapine (30 mg/kg p.o.). The rats were killed at the end of the 14th day of treatment. Brain tissue was examined with regard to antioxidant/oxidant biochemical parameters.Results: Although glutathione (tGSH) and nitric oxide (NO) end product mean scores were found to be statistically higher in the control group when compared with the cisplatin group (72.44% and 61.99% percentage change [PC], respectively), malondialdehyde (MDA), myeloperoxidase (MPO), and 8‐hydroxyguanine (8‐OH‐GUA) mean scores were statistically lower in the control group in comparison with the cisplatin group (−55.48%, −67.99%, and −48.81% PC, respectively; P < 0.01). Finally, tGSH and NO end product levels were restored to normal (85.90% and 55.30% PC, respectively), and MDA, MPO, and 8‐OH‐GUA were significantly reduced by treatment with mirtazapine (−60.50%, −78.59%, and −38.10% PC, respectively; P < 0.01).Conclusion: Mirtazapine has chemoprotective effects against cisplatin‐induced oxidative stress and DNA damage in the rat brain, which may be attributed to its antioxidant capabilities. It would be useful to investigate whether cisplatin at the desired doses can be given concurrently with mirtazapine.
- 1 November 2011
- Published by Elsevier in Journal of Affective Disorders
- Vol. 134 (1-3) , 257-265
Ongoing or re-emerging subjective insomnia symptoms after full/partial remission or recovery of major depressive disorder mainly with the selective serotonin reuptake inhibitors and risk of relapse or recurrence: A 52-week follow-up study
- 1 November 2011
- Published by Elsevier in Journal of Affective Disorders
- Vol. 134 (1-3) , 257-265
Ongoing or re-emerging subjective insomnia symptoms after full/partial remission or recovery of major depressive disorder mainly with the selective serotonin reuptake inhibitors and risk of relapse or recurrence: A 52-week follow-up study